GLP-1 Weight Loss Telehealth in Florida

Florida is home to roughly 22.6 million people, and about 30.6% of Florida adults have obesity. Whether treatment is appropriate for any individual is a licensed physician's decision.

Whether you live in Miami, Orlando, Tampa or anywhere else in Florida, you can start with an online medical assessment once we open, and a physician licensed in Florida reviews it and decides whether telehealth treatment is right for you.

Florida telehealth rules: Florida allows synchronous and asynchronous telehealth for non-controlled prescriptions. Compounded semaglutide and tirzepatide can be prescribed by Florida-licensed physicians and dispensed via state-licensed compounding pharmacies.

Ask what is actually in the proposed prescription. When comparing semaglutide care in Florida, request the exact product name, formulation and ingredients the clinician is considering for you. If the proposal includes an added ingredient, ask why it is being considered and what the clinician can explain about that choice. Do not assume a combination described in an advertisement is the same product you would receive. Our guide to compounded semaglutide and FDA approval helps you prepare questions about product status without treating a compounded preparation as interchangeable with a branded medicine.

Identify the pharmacy and clarify instructions. If medication is prescribed, ask which pharmacy will dispense it, who will explain the label and how to raise a question before using it. The compounding-pharmacy guide provides questions for a proposed compounded preparation; this prescription-label guide helps you review the actual product with the pharmacist. Get the treating professional's full name and credential. Check the appropriate Florida physician and pharmacy lookups in the verified facts, and ask where to verify a clinician with another professional credential.

Compare the complete care plan and bill. Before booking, ask what the medical assessment involves, which records to provide and what further information the clinician may need before a treatment decision. Prepare your medicines, allergies and questions using the first-telehealth-visit guide. Request separate prices for the assessment, medication, supplies, delivery and follow-up, with optional services identified. These telehealth-subscription questions help you clarify renewals, cancellation terms and charges if no prescription is issued. Ask who handles follow-up and how to contact the treating team after the visit.

Florida made a deliberate choice about where its telehealth rules live: it put them in one statute, then repealed the competing rule. Section 456.47 of the Florida Statutes, titled Use of telehealth to provide services, took effect on July 1, 2019, and three and a half months later the Board of Medicine repealed its own rule 64B8-9.0141, Standards for Telemedicine Practice, effective October 14, 2019. The repeal notice published on August 23, 2019 said the proposed rule repeal was intended to delete an unnecessary rule. So when someone tells you what the Florida Board of Medicine's telemedicine rule requires, ask which rule. For physicians the answer now lives in the statute.

On licensing, section 456.47(1)(b) names three routes rather than one. A telehealth provider is someone licensed under a listed Florida practice act, chapter 458 for medical doctors and chapter 459 for osteopathic physicians among them, or someone licensed under a multistate health care licensure compact of which Florida is a member state, or someone registered under subsection (4). That third route is real and specific: a health care professional not licensed in this state may provide health care services to a patient located in this state using telehealth if the professional registers with the applicable board, or the department if there is no board. Registration turns on a completed application plus an active, unencumbered license issued by another state, the District of Columbia, or a United States possession or territory that is substantially similar to the Florida license, no disciplinary action relating to that license during the 5-year period immediately prior to the submission of the application, professional liability coverage, and a duly appointed registered agent for service of process in this state. It also carries a ceiling: a registrant may not open an office in this state and may not provide in-person health care services to patients located in this state. The registration buys a screen, not a clinic. A related belief is worth correcting here. Florida joined the Interstate Medical Licensure Compact in 2024, after Senate Bill 7016 passed, and the Board of Medicine's own explanation is precise about what that does: a physician completes one application to become eligible to receive separate licenses from each Compact member jurisdiction, and those licenses are issued by the individual member jurisdictions just as they would be using the standard licensing process. The compact streamlines the paperwork. It does not let a doctor treat a Floridian on an out-of-state license alone.

How the relationship starts is the part Florida writes most plainly, and it is one sentence in 456.47(2)(b). A telehealth provider may use telehealth to perform a patient evaluation, and if that evaluation is sufficient to diagnose and treat the patient, the provider is not required to research a patient's medical history or conduct a physical examination before using telehealth to provide care. Read the condition and not only the permission: what excuses the physical exam is an evaluation sufficient to diagnose and treat, and 456.47(2)(a) separately binds the provider to the prevailing professional standard of practice for a health care professional who provides in-person health care services to patients in this state. Nowhere in the section is there an in-person visit requirement for a non-controlled prescription. The hard lines sit elsewhere in the same subsection, and there are two of them: 456.47(2)(c) forbids using telehealth to prescribe a controlled substance listed in Schedule II unless it is prescribed for a psychiatric disorder, inpatient treatment at a licensed hospital, a patient receiving hospice services, or a resident of a nursing home facility, and 456.47(2)(f) separately forbids using telehealth to perform an abortion.

What counts as telehealth is wider than people assume in one direction and narrower in another. Florida defines it as the use of synchronous or asynchronous telecommunications technology by a telehealth provider to provide health care services, naming assessment, diagnosis, consultation, treatment and monitoring among them. The definition sets no audio-visual requirement, and asynchronous care is named in the text rather than merely tolerated. Then the same definition closes with an exclusion, and the exclusion is the trap: the term does not include e-mail messages or facsimile transmissions. A thread of emails with a clinician is not a telehealth encounter in Florida, however thorough it is.

Two provisions are unusually specific about where a patient stands. Subsection (5) is a venue rule: any act that constitutes the delivery of health care services is deemed to occur at the place where the patient is located at the time the act is performed or in the patient's county of residence, and venue for a civil or administrative action initiated by the department, the appropriate board, or a patient who receives telehealth services from an out-of-state telehealth provider may be located in the patient's county of residence or in Leon County. Set next to the registered agent requirement, that keeps the forum close to the patient rather than the provider. Subsection (4)(h) then orders the Department of Health to publish on its website, for each registrant and to the extent applicable, a five-year disciplinary history, the medical malpractice insurance provider and policy limits including whether the policy covers claims that arise in this state, and the name and address of the registered agent designated for service of process in this state. Subsection (4)(c) goes further and requires the registrant's own website to prominently display a hyperlink to that department page. Florida turned looking up your provider into an obligation on the provider's own site.

The medicine itself travels under a separate statute. Under 465.0156, any pharmacy located outside Florida that ships, mails, or delivers a dispensed medicinal drug into the state is considered a nonresident pharmacy, must be registered with the board, and must provide a toll-free telephone service during its regular hours of operation on not less than 6 days per week and for a minimum of 40 hours per week, with that number disclosed on the label affixed to each container of dispensed medicinal drugs. Section 465.0156(7) also makes it unlawful for a nonresident pharmacy that is not registered to advertise its services in this state. If what ships is a compounded sterile product, 465.0158 layers on a nonresident sterile compounding permit, granted only on an application that includes proof of nonresident pharmacy registration or of an outsourcing facility license, a written attestation that the product meets or exceeds this state's standards for sterile compounding, sterile compounding policies and procedures complying with chapter 797 of the United States Pharmacopoeia, and a current inspection report. Those two sections and 456.47 are linked below in full.

You can verify any physician's Florida license at the Florida Board of Medicine.